| abstract |
Itnbecomes a topically applied composition, in particularnfor use in the infantnor toddler, wherein the composition is a hydrophilicnLiquid,nat least one anti-inflammatorynActive ingredient and at least one vehicle for the active ingredientnand the carrier substancenwith the hydrophilic liquidnlamellar, layered double membrane forms.nThe anti-inflammatorynActive substance is homogeneously dispersed in the lamellar double membrane. |